Gyre Therapeutics, Inc.
Gyre Therapeutics develops small-molecule treatments for organ fibrosis.
10-QNov 6Latest SEC filing
Nov 10Latest story
November 2026
October 2026
August 2026
July 2026
Gyre Therapeutics develops small-molecule treatments for organ fibrosis.
November 2026
October 2026
August 2026
July 2026